← Back to Search

Behavioral Intervention

Digital storytelling group for Influenza

N/A

Waitlist Available

Research Sponsored by Denver Health and Hospital Authority

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, up to 1 year

Awards & highlights

Study Summary

This trial aims to address the unequal impact of seasonal influenza on Black children by developing and testing a Digital Storytelling intervention to increase influenza vaccination rates in Black children aged 6 months to 5 years

Who is the study for?

This trial is for Black children aged 6 months to 5 years. The goal is to explore and test a new way of encouraging flu vaccinations through digital storytelling, aiming to reduce the gap in vaccination rates.Check my eligibility

What is being tested?

The study is testing whether using digital stories can help increase flu vaccination rates among young Black children. It's an innovative approach that involves community engagement and could serve as a model for addressing similar health disparities.See study design

What are the potential side effects?

Since this intervention uses digital storytelling rather than medical treatments, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Child influenza vaccination status at influenza season's end (defined as March 31, 2025 for season 1 and March 31, 2026 for season 2 if a 2nd season of recruitment is necessary)

Secondary outcome measures

Intervention Acceptability

Intervention Appropriateness

Intervention Feasibility

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Digital storytelling groupExperimental Treatment1 Intervention

Caregivers will receive a series of digital stories by text message designed to increase influenza vaccine confidence.

Group II: Control groupActive Control1 Intervention

Caregivers will receive standard care.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Denver Health and Hospital AuthorityLead Sponsor

101 Previous Clinical Trials

400,197 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the necessary criteria to participate in this clinical study?

"Individuals aged between 18 and 90 years with a confirmed influenza diagnosis are eligible for enrollment in this research, which aims to recruit approximately 200 participants."

Answered by AI

Are there any available openings for patients to participate in this medical study?

"Records from clinicaltrials.gov show that this particular study is not actively seeking participants. Its initial posting date was 5/1/2024, with the most recent update made on 2/15/2024. Despite its current inactivity, there are presently 120 alternative studies open for patient recruitment."

Answered by AI

Are individuals older than 35 years of age eligible to participate in this clinical trial?

"Participants aged between 18 and 90 are eligible for enrollment in this clinical investigation. Among the ongoing trials, there are 34 studies targeting individuals under 18 years old and 76 focused on those above the age of 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities

2024. "Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06274359.

All > Influenza